General Information of This Metabolic Reaction (MR) (ID:
MR002150) |
Formula |
|
Reactant |
Primidone |
Product |
Phenobarbital |
Reactant Info
|
Product Info
|
Metabolic Enzyme
|
Cytochrome P450 2E1 (CYP2E1)
|
DME Info
|
Cytochrome P450 2C9 (CYP2C9)
|
DME Info
|
Mephenytoin 4-hydroxylase (CYP2C19)
|
DME Info
|
|
|
|
|
|
|
|
Other MR(s) Related to The Reactant of This MR |
Other MR(s) That Metabolize The Reactant of This MR
|
|
Other MR(s) Related to The Product of This MR |
Other MR(s) That Produce The Product of This MR
|
|
References |
1 |
Physiologically based pharmacokinetics model of primidone and its metabolites phenobarbital and phenylethylmalonamide in humans, rats, and mice Drug Metab Dispos. 1998 Jun;26(6):585-94.
|
2 |
Blood and cerebrospinal fluid pharmacokinetics of primidone and its primary pharmacologically active metabolites, phenobarbital and phenylethylmalonamide in the rat Eur J Drug Metab Pharmacokinet. 1999 Jul-Sep;24(3):255-64. doi: 10.1007/BF03190029.
|
3 |
Pharmacogenetic roles of CYP2C19 and CYP2B6 in the metabolism of R- and S-mephobarbital in humans. Pharmacogenetics. 2004 Aug;14(8):549-56.
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.